No Data
Express News | GlycoMimetics Inc - on Dec 19, Nasdaq Grants GlycoMimetics 180 Days to Regain Compliance
GlycoMimetics | 10-Q: Q3 2024 Earnings Report
Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024
GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting
Express News | Adage Capital Management LP Reports 7.9% Stake in GlycoMimetics Inc as of Oct 29 - SEC Filing
M&A Deals Roundup: AbbVie, Blackstone, Take-Two Interactive and More